期刊文献+

丙型肝炎病毒核心蛋白下调沉默信息调节因子2相关酶1-AMP激活蛋白激酶信号通路活性致肝细胞能量代谢紊乱 被引量:6

Hepatitis C virus core protein induces energy metabolism disorders of hepatocytes by down-regulation of silent mating type information regulation 2 homolog-1 and adenosine monophosphate-activated protein kinase signaling pathway
原文传递
导出
摘要 目的探讨沉默信息调节因子2相关酶1(SIRT1)-AMP激活的蛋白激酶(AMPK)信号通路在HCV核心蛋白所致肝细胞能量代谢紊乱中的作用。方法pcDNA3.1-core重组质粒转染HepG2细胞,流式细胞仪测定表达HCV核心蛋白的HepG2细胞的活性氧(ROS),液体闪烁计数仪测定ATP/ADP比例和AMPKa2酶活性,比色法测定烟酰胺腺嘌呤二核苷酸氧化态与还原态之比(NAD+/NADH),荧光定量检测SIRT1酶活性,RT-PCR和Western印迹检测SIRT1、AMPKa2的表达。计量资料比较采用t检验。结果Western印迹检测证实,HepG2细胞表达相对分子质量为22000的HCV核心蛋白。与HepG2细胞相比,表达HCV核心蛋白的HepG2细胞ROS水平升高(1.0±0.1比4.0±0.5,t=14.411,P〈0.01);ATP/ADP比例无明显变化(8.2±2.2比9.3±2.8,t=0.757,P〉0.05);AMPKa2酶活性(0.8±0.2比0.2±0,t=7.345,P〈0.01)明显降低;NAD+/NADH比例明显降低(0.08±0.02比0.024-0,t=7.348,P〈0.01);SIRT1酶活性[(0.30±0.05)pmol·μg-1·min。比(0.15±0.04)pmol·μg-1·min,t=5.738,P〈0.01)]明显降低;SIRT1 mRNA(0.8±0.2比0.4±0.1,t=4.382,P〈0.01)和AMPKd2mRNA(0.9±0.3比0.2±0,t=5.715,P〈0.01)表达明显降低;SIRT1蛋白(0.8±0.2比0.3±0,t=5.941,P〈0.01)和磷酸化AMPK蛋白(0.5±0.1比0.1±0,t=9.608,P〈0.01)水平明显降低。结论HCV核心蛋白能下调SIRT1-AMPK信号通路活性,导致肝细胞能量代谢紊乱。 Objective To study the role of silent mating type information regulation 2 homolog-1 (SIRT1)-adenosine monophosphate (AMP)-activated protein kinase (AMPK) signaling pathway in hepatitis C virus core protein (HCV-core) induced energy metabolism disorders of hepatocytes. Methods HepG2 ceils were transfected with recombined expressed plasmid pcDNA3. 1-core. The level of reactive oxygen species (ROS), value of ATP/ADP and activity of AMPK α-2, and nicotinamide adenine dinucleotide (NAD)+/NADH in HepG2 cells expressing HCV-core weredetected by flow cytometry, liquid scintillation counter and chromatometry, respectively. The activity of SIRT1 was detected with a {luorometric assay kit. Reverse transcription polymerase chain reaction (RT-PCR) and Western blot assay were performed to examine the expression of SIRT1 and AMPK α- 2. Quantitative data were analyzed by t-test. Results It was confirmed by Western blot assay that HepG2 cells expressed HCV-core with relative molecular weight of 22 000. Compared to HepG2 cells, the level of ROS in HepG2 cells expressing HCV-core was significantly increased (1.0±0.1 vs 4.0±0.5, t=14. 411, P〈0. 01), the values of ATP/ADP were similar (8. 2±2. 2 vs 9. 3±2. 8, t= 0. 757, P〉0.05), AMPK α-2 (0.8+_0.2 vs 0.2-1-0, t=7. 345, P〈0.01), the values of NAD+ / NADH (0. 08_+0. 02 vs 0. 02±0, t=7. 348, P〈0. 01), the activity of SIRT1 [(0. 30±0.05) pmol.μg-1 . min -1 vs (0. 15μ0. 04) pmol .μg-1 . min-1, t=5. 738, P〈0. 01] and the mRNA levels of SIRT1 (0.82±0.2 vs 0.4±0.1, t=4. 382, P〈0.01) and AMPK α-2 mRNA (0.9± 0.3 vs 0.2±0, t=5. 715, P〈0.01), and the expression of SIRT1 (0.8±0.2 vs 0.3±0, t=5. 941, P〈0.01) and phosphorylated AMPK protein (0.5±0. 1 vs 0. 1±0, t=9. 608, P〈0.01) were all significantly decreased. Conclusion HCV core protein induces energy metabolism disorders of hepatocytes by down-regulation of SIRT1-AMPK signaling pathway.
出处 《中华传染病杂志》 CAS CSCD 北大核心 2013年第2期71-76,共6页 Chinese Journal of Infectious Diseases
基金 黑龙江省教育厅科学研究资助项目
关键词 肝炎病毒属 病毒核心蛋白质类 能量代谢 沉默信息调节因子2相关酶1 蛋白 激酶类 Hepacivirus Viral core proteins Energy metabolism SIRT1 Protein kinases
  • 相关文献

参考文献9

  • 1Jian Wu Y, Shu Chen I., Gui Qiang W. Effects of fatty liver and related factors on the efficacy of combination antiviral therapy in patients with chronic hepatitis C. Liver Int, 2006. 26: 166-172.
  • 2YuJW, Sun l.J, Zhao YH. et al. The effect of medormin on the efficacy of antiviral therapy in patients with genotype 1 chronic hepatitis C and insulin resistance. Int J Infect Dis, 2012, 16, e436-441.
  • 3于建武,孙丽杰,康鹏,赵勇华,颜炳柱,李树臣.二甲双胍对胰岛素抵抗的基因1型慢性丙型肝炎患者抗病毒疗效的影响[J].中华传染病杂志,2012,30(4):215-220. 被引量:5
  • 4孙丽杰,李明荣,于建武,李树臣.丙型肝炎病毒核心蛋白转染HepG2细胞对其p53表达的影响[J].中华实验和临床病毒学杂志,2006,20(4):355-357. 被引量:8
  • 5Welzel TM, Graubard BI, Zeuzem S, et al. Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database.Hepatology, 2011, 54: 463-471.
  • 6Mankouri J, Tedbury PR, Gretton S, et al. Enhanced hepatitis C virus genome replication and lipid accumulation mediated by inhibition of AMP-activated protein kinase. Proe Natl Aead Sci USA, 2010, 107:11549-11554.
  • 7Wang T, Campbell RV, Yi MK, et al. Role of hepatitis C virus core protein in viral-induced mitochondrial dysfunction. J Viral Hepat, 2010, 17: 784-793.
  • 8Miller RA, Birnbaum MJ. An energetic tale of AMPK independent effects of metformin. J Clin Invest, 2010, 120 : 2267-2270.
  • 9Suchankova G, Nelson LE, Gerhart-Hines Z, et al. Concurrent regulation of AMP-activated protein kinase and SIRT1 in mammalian cells. Biochem Biophys Res Commun, 2009, 378: 836-841.

二级参考文献12

  • 1于建武,王贵强,赵勇华,陈焕永,王春义,李树臣.影响聚乙二醇干扰素α-2a联合利巴韦林治疗慢性丙型肝炎疗效因素分析[J].中华内科杂志,2006,45(5):410-411. 被引量:4
  • 2Gao B, Hong F, Radaeva S. Host factors and failure of interferon-alpha treatment in hepatitis C virus. Hepatology, 2004,39 :880-890.
  • 3Jian Wu Y, Shu Chen L, Gui Qiang W. Effects of fatty liver and related factors on the efficacy of combination antiviral therapy in patients with chronic hepatitis C. Liver Int, 2006,26 : 166-172.
  • 4Kahn BB, Alquier T, Carling D, et al. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab, 2005,1:15-25.
  • 5Romero-Gomez M, Del Mar Viloria M, Andrade RJ, et al. Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients. Gastroenterology, 2005,128: 636-641.
  • 6Romero-Gomez M, Diago M, Andrade R J, et al. Treatment of insulin resistance with metformin in naive gcnotype 1 chronic hepatitis C patients receiving peginterferon alfa-2a plus ribavirin. Hepatology, 2009,50: 1702-1708.
  • 7Khattab M, Emacl M, Abdelaleem A, et al. Pioglitazone improves virological response to peginterferon alpha-2b/ ribavirin combination therapy in hepatitis C genotype 4 patients with insulin resistance. Liver Int, 2010, 30: 447- 454.
  • 8于建武,王贵强,赵勇华,李树臣.脂肪肝及其相关因素对联合抗病毒治疗慢性丙型肝炎效果的影响[J].中华传染病杂志,2007,25(7):426-430. 被引量:5
  • 9Ruggieri A,Murdolo M,Harada T,et al.Cell cycle perturbation in a human hepatoblastoma cell line constitutively expressing hepatitis C virus core protein.Arch Virol,2004,149:61-74.
  • 10Hahn CS,Cho YG,Kang BS,et al.The HCV core protein acts as a positive regulator of Fas mediated apoptosis in a human lymphoblastoid T cell line.Virology,2000,276:127-137.

共引文献10

同被引文献36

引证文献6

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部